{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:34Z","timestamp":1759403434869,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.vaccine.2020.09.059","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T03:20:33Z","timestamp":1601608833000},"page":"7526-7532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial"],"prefix":"10.1016","volume":"38","author":[{"given":"Mbayame","family":"Niang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2574-0542","authenticated-orcid":false,"given":"Meagan E.","family":"Deming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Goudiaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousmane M.","family":"Diop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ndongo","family":"Dia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldiouma","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3138-5965","authenticated-orcid":false,"given":"Justin R.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doudou","family":"Diop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen D.C.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5018-9591","authenticated-orcid":false,"given":"Kathryn E.","family":"Lafond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Alain","family":"Widdowson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Victor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.09.059_b0005","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/jmv.21665","article-title":"Viral etiology of respiratory infections in children under 5 years old living in tropical rural areas of Senegal: the EVIRA project","volume":"82","author":"Niang","year":"2010","journal-title":"J Med Virol"},{"issue":"10127","key":"10.1016\/j.vaccine.2020.09.059_b0010","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"The Lancet"},{"issue":"16","key":"10.1016\/j.vaccine.2020.09.059_b0015","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1017\/S0950268818002418","article-title":"Estimation of the burden of flu-association influenza-like illness visits on total clinic visits through the sentinel influenza monitoring system in Senegal during the 2013\u20132015 influenza seasons","volume":"146","author":"Niang","year":"2018","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2020.09.059_b0020","first-page":"1","article-title":"Effectiveness of seasonal influenza vaccination in children in Senegal during a year of vaccine mismatch: a cluster-randomized trial","author":"Diallo","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"45","key":"10.1016\/j.vaccine.2020.09.059_b0025","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1016\/j.vaccine.2016.07.045","article-title":"A global review of national influenza immunization policies: analysis of the 2014 WHO\/UNICEF Joint Reporting Form on immunization","volume":"34","author":"Ortiz","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.09.059_b0030","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.vaccine.2017.07.053","article-title":"Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004\u20132015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenz","volume":"35","author":"Palache","year":"2017","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.09.059_b0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM200103223441204","article-title":"The Japanese experience with vaccinating schoolchildren against influenza","volume":"344","author":"Reichert","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.09.059_b0040","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.2010.250","article-title":"Effect of influenza vaccination of children on infection rate in Hutterite communities: follow-up study of a randomized trial","volume":"303","author":"Loeb","year":"2010","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.vaccine.2020.09.059_b0045","doi-asserted-by":"crossref","first-page":"e940","DOI":"10.1016\/S2214-109X(19)30079-8","article-title":"Efficacy of inactivated trivalent influenza vaccine in rural India: a 3-year cluster-randomised controlled trial","volume":"7","author":"Sullender","year":"2019","journal-title":"Lancet Global Health"},{"issue":"20","key":"10.1016\/j.vaccine.2020.09.059_b0050","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1073\/pnas.1802479115","article-title":"Optimizing the impact of low-efficacy influenza vaccines","volume":"115","author":"Sah","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.09.059_b0055","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/ije\/dyt100","article-title":"Profile: the Niakhar health and demographic surveillance system","volume":"42","author":"Delaunay","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2020.09.059_b0060","doi-asserted-by":"crossref","first-page":"e955","DOI":"10.1016\/S2214-109X(16)30201-7","article-title":"Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial","volume":"4","author":"Victor","year":"2016","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.vaccine.2020.09.059_b0065","unstructured":"World Health Organization. Recommended composition of influenza virus vaccines for use in the 2008\u20132009 influenza season. 2008:1\u20137. https:\/\/www.who.int\/influenza\/vaccines\/vaccinerecommendations1\/en\/index3.html."},{"year":"2011","series-title":"Manual for the laboratory diagnosis and virological surveillance of influenza","author":"WHO Global Influenza Surveillance Network","key":"10.1016\/j.vaccine.2020.09.059_b0070"},{"key":"10.1016\/j.vaccine.2020.09.059_b0075","unstructured":"United States Food and Drug Administration. Guidance for Industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines; 2019."},{"key":"10.1016\/j.vaccine.2020.09.059_b0080","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/infdis\/jit372","article-title":"Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children","volume":"208","author":"Ng","year":"2013","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2020.09.059_b0085","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children","volume":"30","author":"Black","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.09.059_b0090","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/jiu186","article-title":"Association between antibody titers and protection against influenza virus infection within households","volume":"210","author":"Tsang","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.09.059_b0095","unstructured":"World Health Organization. Guidelines for WHO\/EPI collaborative studies on poliomyelitis: standard procedure for determining immunity to poliovirus using the microneutralization test; 1993."},{"issue":"8","key":"10.1016\/j.vaccine.2020.09.059_b0100","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/507309","article-title":"Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine\u2010naive 5\u20138\u2010year\u2010old children","volume":"194","author":"Neuzil","year":"2006","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2020.09.059_b0105","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1010331","article-title":"Oil-in-water emulsion adjuvant with influenza vaccine in young children","volume":"365","author":"Vesikari","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.09.059_b0110","unstructured":"World Health Organization. Influenza surveillance outputs; n.d. https:\/\/www.who.int\/influenza\/resources\/charts\/en\/ (accessed August 20, 2019)."},{"issue":"11","key":"10.1016\/j.vaccine.2020.09.059_b0115","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1111\/ajt.14511","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices-United States, 2017-18 influenza season","volume":"17","author":"Grohskopf","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2020.09.059_b0120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1542\/peds.69.4.404","article-title":"Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months","volume":"69","author":"Bernstein","year":"1982","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2020.09.059_b0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/INF.0000000000002227","article-title":"Safety and immunogenicity of a full-dose, split-virion, inactivated, quadrivalent influenza vaccine in healthy children 6-35 months of age: a randomized controlled clinical trial","volume":"38","author":"Robertson","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"03","key":"10.1016\/j.vaccine.2020.09.059_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6703a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices\u2014United States, 2018\u201319 influenza season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2020.09.059_b0135","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/14760584.2019.1635462","article-title":"Influenza vaccine programs for children in low- and middle-income countries: current status and way forward","volume":"18","author":"Ortiz","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"43","key":"10.1016\/j.vaccine.2020.09.059_b0140","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1016\/j.vaccine.2018.08.032","article-title":"Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-na\u00efve children in a randomized clinical trial in rural Senegal","volume":"36","author":"Diallo","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.09.059_b0145","unstructured":"World Health Organization. WHO UNICEF estimates time series for Senegal. WHO Vaccine-Preventable Dis Monit Syst; 2019. http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/estimates?c=SEN (accessed September 9, 2019)."},{"issue":"1","key":"10.1016\/j.vaccine.2020.09.059_b0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(18)30496-X","article-title":"Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017","volume":"7","author":"Troeger","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.vaccine.2020.09.059_b0155","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/S1473-3099(18)30490-0","article-title":"The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review","volume":"19","author":"Lindsey","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20312305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20312305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:47:26Z","timestamp":1759402046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20312305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":31,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0264410X20312305"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.09.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.09.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}